Blood test markers in sudden worsening of pulmonary fibrosis
Part of Lungs & breathing clinical trials.
This study looks at whether routine blood test results can help doctors understand and manage sudden flare-ups of idiopathic pulmonary fibrosis (IPF), a lung disease. If you are admitted to the hospital with a sudden worsening, your blood tests may provide important clues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with IPF (a specific type of lung scarring) by a doctor.
- You are in the hospital because your IPF suddenly got worse (for example, increased shortness of breath) within the last month.
- You were admitted within 72 hours of your symptoms getting worse.
- You (or your legal representative) can give permission to join the study.
- Your worsening is not due to another cause like a bacterial infection, a blood clot in the lungs, heart failure, or a collapsed lung.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with idiopathic pulmonary fibrosis (IPF) who are currently having a sudden worsening of breathing symptoms. It may help doctors better understand what happens during these flare-ups and how to manage them.
This trial tests whether giving a medication called intravenous immunoglobulin (IVIG) can help people with IPF who are hospitalized for a sudden worsening of their lung condition. The treatment aims to reduce inflammation and improve recovery.
This Phase 3 trial studies whether glucocorticoid (steroid) medicine helps people with idiopathic pulmonary fibrosis (IPF) who have a sudden flare-up, compared with an inactive placebo. You may be helped if steroids improve breathing and recovery during these acute episodes, but the study is designed to test that clearly.
This study monitors your vital signs before and after a sudden worsening (flare-up) of IPF. It uses a wearable device (Bora Band®) to track your health and help doctors better understand and manage these events.
This trial tests a treatment to reduce certain antibodies in the blood that may be making your idiopathic pulmonary fibrosis (IPF) worse. The goal is to slow down the progression of the disease and help you breathe easier.
This study uses detailed CT scans to find better ways to treat idiopathic pulmonary fibrosis (IPF). It may help doctors choose the right treatment for each person.
Hear when a new Idiopathic Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.